Læknablaðið - 15.04.2000, Qupperneq 20

FRÆÐIGREINAR / KRANSÆÐAVÍKKANIR Á ÍSLANDI
Lokaorð
Próun kransæðavíkkunaraðgerða hefur verið bylt-
ingarkennd undanfarna tvo áratugi. Tíðni þessara
aðgerða hérlendis er há miðað við fólksfjölda, árang-
ur hefur verið góður og jafnan kappkostað að taka
nýjungar í tækni og lyfjameðferð í notkun þegar þær
hafa sannað sig í erlendum rannsóknum. Kransæða-
víkkanir eru sérhæfðar hátækniaðgerðir sem eiga eft-
ir að þróast enn frekar á næstu öld. Aukin tækni,
reynsla og framfarir í meðferð hafa orðið til þess að
sá sjúklingahópur sem gagn hefur af kransæðavíkkun
fer ört vaxandi. Mikilvægt er að búið sé vel að þessari
meðferð hér á landi og vinnubrögð samhæfð.
Heimildir
1. Gríientzig AR. Transluminal dilatation of coronary artery
stenosis [letter to editor]. Lancet 1978; 1:263.
2. Myler RK, Stertzer SH. Coronary and peripheral angioplasty:
historical perspective. In: Topol EJ, ed. Textbook of interventio-
nal cardiology. London: WB Saunders Company; 1990:187-98.
3. Altmann DB, Racz M, Battleman DS, Bergman G, Spokojny
A, Hannan EL, et al. Reduction in angioplasty complications
after the introduction of coronary stents: results from a conse-
cutive series of 2242 patients. Am Heart J 1996; 132: 503-7.
4. Eeckhout E, Wijns W, Meier B, Goy JJ. Indications for intra-
coronary stent placement: the European view. Eur Heart J
1999; 20:1014-9.
5. Topol EJ, Leya F, Pinkerton CA, Withlow PL, Hofling B, Sim-
onton CA, et al. A comparison of direct atherectomy with
coronary angioplasty in patients with coronary artery disease.
The CAVEAT Study Group. N Engl J Med 1993; 329: 221-7.
6. Baim DS, Cutlip DE, Sharma SK, Ho KK, Fortuna R, Schreiber
TL, et al. Final results of the Balloon vs Optimal Atherectomy
Trial (BOAT) [see comments]. Circulation 1998; 97:322-31.
7. Kini A, Marmur JD, Duvvuri S, Dangas G, Choudhary S,
Sharma S. Rotational atherectomy: improved procedural out-
come with evolution of technique and equipment. Single-
center results of first 1,000 patients. Cathet Cardiovasc Inter-
vent 1999; 46:305-11.
8. Stone GW, de Marchena E, Dageforde D, Foschi A, Muhle-
stein JB, Mclvor M, et al. Prospective, randomized, multicen-
ter comparison of laser facilitated balloon angioplasty versus
stand-alone balloon angioplasty in patients with obstructive
coronary artery disease. The Laser Angioplasty Versus Angio-
plasty (LAVA) Trial Investigators. J Am Coll Cardiol 1997; 30:
1714-21.
9. Safian RD, Freed M. Overview of interventional devices. In:
Freed M, Grines C, Safian RD, eds. The new Manual of
Interventional Cardiology. Birmingham, Michigan: Physici-
ans’ Press; 1996:195-215.
10. Windecker S, Maier-Rudolph W, Bonzel T, Heyndrickx G,
Lablanche JM, Morice MC, et al. Interventional Cardiology in
Europe 1995. Eur Heart J 1999 20:484-95.
11. Henderson RA, Pocock SJ, Sharp J, Nanchahal K, Sculpher
MJ, Buxton MJ. Long-term results of RITA-I trial: clinical and
cost comparison of coronary angioplasty on coronary bypass
surgery grafting. Randomised Intervention for Treatment of
Angina. Lancet 1998; 352:1419-25.
12. The BARI Investigators. Comparison of coronary bypass
surgery with angioplasty in patients with multivessel disease. N
Engl J Med 1996; 335:217-25.
13. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL,
Grosswald R, Liberman HA, et al. Influence of diabetes mell-
itus on early and late outcome after percutaneous translum-
inal coronary angioplasty. Circulation. 1995; 91:979-89.
14. Kurbaan AS, Bowker TJ, Ilsley CD, Rickards AF. Impact of
postangioplasty restenosis on comparison of outcome between
angioplasty and bypass grafting: CABRI investigators. Am J
Cardiol 1998; 82: 272-6.
15. DeFeyter PJ. Lipids and coronary restenosis: an elusive link
[editorial]. Eur Heart J 1999; 20:1371-4.
16. Van den Brand MJBM, Nreeman A, Rensing B, Boersma E,
van den Heuvel P, Penn I, et al. Comparison of the extent of
revascularization and event free survival in the angioplasty
arms of two randomized trials of coronary angioplasty versus
surgery for multivessel coronary artery disease [abstract]. Eur
HeartJ 1999; 20/Suppl.: 153.
17. Van Belle E, Bauters C, Hubert E, Bodrt JC, Abolmaalik K,
Meurice T, et al. Restenosis rates in diabetic patients.a com-
parison of coronary stenting and balloon angioplasty in native
coronary vessels [see comments]. Circulation 1997; 96:1454-60.
18. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF,
Bucher TA, et al. Increased restenosis in diabetes mellitus
after coronary interventions is due to exaggerated intimal
hyperplasia. A serial intravascular ultrasound study. Circula-
tion 1997; 95:1366-9.
19. Gum PA, O’Keefe JH, Jr., Borkon AM, Spertus JA, Bateman
TM, McGraw JP, et al. Bypass surgery versus coronary angio-
plasty for revascularization of treated diabetic patients. Circu-
lation 1997; 96/Suppl. 9:11-7-10.
20. The TIMI IIIB Investigators. Effects of tissue plasminogen
activator and a comparison of early invasive and conservative
strategies in unstable angina and non-Q-Wave myocardial
infarction: Results of the TIMIIIIB trial. Circulation 1994; 89:
1545-56.
21. Boden WE, O’Rourke RA, Crawford MH, Blaustein AS,
Deedwania PC, Zoble RG, et al. Outcomes in patients with
acute non-Q-wave myocardial infarction randomly assigned to
an invasive as compared with a conservative management
strategy. Veterans Affairs Non-Q-Wave Infarction Strategies
in Hospital (VANQWISH) Trial Investigators [see com-
ments]. N Engl J Med 1998; 338:1785-92.
22. FRISC II Investigators. Invasive compared with non-invasive
treatment in unstable coronary-artery disease: FRISC II pro-
spective randomised multicentre study. Lancet 1999; 354: 708-
15.
23. Michels KB, Yusuf S. Does PTCA in acute myocardial infarc-
tion affect mortality and reinfarction rates? A quantitative
overview (meta-analysis) of the randomized clinical trials.
Circulation 1995; 91:476-85.
24. A clinical trial comparing primary coronary angioplasty with
tissue plasminogen activator for acute myocardial infarction.
The Global Use of Strategies to Open Occluded Coronary
Arteries in Acute Coronary Syndromes (GUSTO Ilb) Angio-
plasty Substudy Investigators [published erratum appears in N
Engl J Med 1997; 337:287] [see comments]. N Engl J Med 336:
1621-8.
25. Zijlstra F, Hoorntje JCA, de Boer M-J, Reiffers S, Miedema K,
Ottervanger JP, et al. Long-term benefit of primary angio-
plasty as compared with thrombolytic therapy for acute myo-
cardial infarction. N Engl J Med 1999; 341:1413-9.
26. Guðnason Þ, Þorgeirsson G, Eyjólfsson K, Jónmundsson EH.
Tafarlaus kransæðavíkkun. Nýjung í meðferð bráðrar krans-
æðastíflu á íslandi. Læknablaðið 1996; 82: 269-75.
27. van’t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer
MJ, Zijlstra F. Clinical presentation and outcome of patients
with early, intermediate and late reperfusion therapy by pri-
mary coronary angioplasty for acute myocardial infarction.
Eur HeartJ 1998; 19:118-23.
28. Garot J, Scherrer-Crosbie M, Monin JL, Du Pouy P, Bourachot
ML, Teiger E, et al. Effect of delayed percutaneous translu-
minal coronary angioplasty of occluded coronary arteries after
acute myocardial infarction. Am J Cardiol 1996; 77: 915-21.
29. Stone GW, Brodie BR, Griffin JJ, Costantini C, Morice MC,
St. Goar FG, et al. Clinical and angiographic follow-up after
primary stenting in acute myocardial infarction: the Primary
Angioplasty in Myocardial Infarction (PAMI) stent pilot trial.
Circulation 1999; 99:1548-54.
30. Brener SJ, Barr LA, Burchenal JE, Katz S, George BS, Jones
AA, et al. Randomized, placebo-controlled trial of platelet
glycoprotein Ilb/IIIa blockade with primary angioplasty for
acute myocardial infarction. ReoPro and Primary PTCA Org-
anization and Randomized Trial (RAPPORT) Investigators.
Circulation 1998; 98: 734-41.
31. Zeymer U, Neuhaus K-L. Clinical trials in acute myocardial
infarction. Curr Opin Cardiol 1999; 14: 392-402.
32. Popma JJ, Piana RN, Prpic R. Clinical trials in interventional
cardiology. Curr Opin Cardiol 1999; 14: 412-8.
33. Stone GW. CADILLAC trial. Plenary Session XII. Late-
breaking clinical trials. Presented at the American Heart
Association 72nd Scientific Sessions, November 7-10, 1999,
http://www.medscape.com
34. Maier W, Enderlin MF, Bonzel T, Danchin N, Heyndrickx G,
Míihlberger V, et al. Audit and quality control in angioplasty in
Europe: procedureal results of the AQUA Study 1997. Eur
Heart J 1999; 20:1261-70.
35. Erbel R, Haude M, Hopp HW, Franzen D, Rupprecht HJ,
Henblein B, et al. Coronary-artery stenting compared with
balloon angioplasty for restenosis after initial balloon angio-
plasty. Restenosis Stent Study Group [see comments]. N Engl
J Med 1998; 339:1672-8.
36. Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani
248 Læknablaðið 2000/86